ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,653Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 2094

$1.08M Total Retail Price of All Prescriptions

Rank: 77 out of 2094

832 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 832 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 832 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 12,522 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 526 459 1 3
SIMVASTATIN 477 386 2 1
AMLODIPINE BESYLATE 421 392 3 2
METOPROLOL TARTRATE 373 347 4 10
FUROSEMIDE 364 345 5 6
LISINOPRIL 359 324 6 7
OMEPRAZOLE 305 286 7 4
METFORMIN HCL 271 211 8 8
DIOVAN 253 235 9 13
HYDROCHLOROTHIAZIDE 217 191 10 12
DONEPEZIL HCL 215 215 11 20
SERTRALINE HCL 209 194 12 26
NEXIUM 207 165 13 16
NAMENDA 189 174 14 32
ATORVASTATIN CALCIUM 181 137 15 5
ZOLPIDEM TARTRATE 181 148 15 14
CYMBALTA 180 144 17 61
WARFARIN SODIUM 178 178 18 11
ATENOLOL 159 134 19 21
LEVOFLOXACIN 158 138 20 70
AZITHROMYCIN 155 132 21 27
LOSARTAN POTASSIUM 144 100 22 17
CITALOPRAM HBR 136 133 23 47
JANUVIA 133 124 24 35
RISPERIDONE 133 131 24 56
PANTOPRAZOLE SODIUM 132 119 26 37
CLOPIDOGREL 122 98 27 22
DIOVAN HCT 110 89 28 28
METOPROLOL SUCCINATE 109 90 29 9
METHYLPREDNISOLONE 108 91 30 127
CRESTOR 106 86 31 15
PRAVASTATIN SODIUM 106 81 31 18
GABAPENTIN 102 72 33 23
PREDNISONE 100 91 34 54
SYNTHROID 99 94 35 44
ALENDRONATE SODIUM 98 93 36 30
TRAZODONE HCL 97 91 37 72
ESCITALOPRAM OXALATE 95 70 38 46
GLIPIZIDE 95 80 38 82
PLAVIX 92 72 40 38
IBUPROFEN 90 76 41 73
CEPHALEXIN 88 78 42 201
GLIMEPIRIDE 86 61 43 31
HYDROCODONE-ACETAMINOPHEN 85 78 S3 44 42
SPIRIVA 85 76 44 60
OXYCODONE HCL-ACETAMINOPHEN 83 53 S2 46 119
ISOSORBIDE MONONITRATE ER 81 70 47 57
TAMSULOSIN HCL 78 73 48 29
BUSPIRONE HCL 77 74 49 159
POTASSIUM CHLORIDE 76 71 50 24
OXYCODONE-ACETAMINOPHEN 76 63 S2 50 40
ADVAIR DISKUS 75 51 52 36
PROAIR HFA 72 31 53 45
ENALAPRIL MALEATE 71 56 54 25
LIPITOR 70 56 55 39
AMOXICILLIN 67 55 56 147
PEN NEEDLE 67 29 56 136
KLOR-CON M20 62 60 58 106
TRAMADOL HCL 61 54 59 33
FLUTICASONE PROPIONATE 60 43 60 41
LANSOPRAZOLE 58 42 61 144
CARVEDILOL 57 52 62 19
HYDRALAZINE HCL 56 48 63 89
EVISTA 54 54 64 131
EXFORGE 53 41 65 105
PAROXETINE HCL 53 45 65 77
GLIPIZIDE ER 53 49 65 126
VENLAFAXINE HCL ER 52 50 68 183
EXELON 52 52 68 111
CLONIDINE HCL 52 31 68 62
DIGOXIN 52 37 68 51
MECLIZINE HCL 51 50 72 103
SINGULAIR 50 37 73 64
INSULIN SYRINGE 50 43 73 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.